Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MVA85A in healthy infants
ISRCTN39705371Phase 3Completed
- Sponsor
- Aeras Global TB Vaccine Foundation
- Start
- Jul 2009
- Modality
- Viral Vector Vaccines → Recombinant Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3 trial of MVA85A, sponsored by Aeras Global TB Vaccine Foundation. Started Jul 2009; status: completed.
02
Drugs
MVA85A
Beyond the preview
Go deeper on ISRCTN39705371.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN39705371.